Discontinuation report MINT-METFORMIN
| Report ID | 108292 |
| Drug Identification Number | 02388774 |
| Brand name | MINT-METFORMIN |
| Common or Proper name | Metformin |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | APPROVED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
| Strength(s) | 850MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 count bottles. |
| ATC code | A10BA |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-03-09 |
| Remaining supply date | 2020-03-09 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | NA |
| Company comments | NA |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-03-09 | English | Compare |
| v2 | 2020-03-09 | French | Compare |
| v3 | 2020-03-10 | English | Compare |
Showing 1 to 3 of 3